Serum levels of eosinophil cationic protein, eosinophil-derived neurotoxin and myeloperoxidase in infections with filariae and schistosomes

被引:43
作者
Tischendorf, FW [1 ]
Brattig, NW [1 ]
Buttner, DW [1 ]
Pieper, A [1 ]
Lintzel, M [1 ]
机构
[1] BERNHARD NOCHT INST TROP MED, DEPT HELMINTHOL, D-20359 HAMBURG, GERMANY
关键词
cationic granule proteins; eosinophil cationic protein; eosinophil-derived neurotoxin; myeloperoxidase; helminth diseases;
D O I
10.1016/S0001-706X(96)00038-1
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The serum levels of three major granulocyte proteins were measured in patients with onchocerciasis, bancroftian filariais and intestinal schistosomiasis and compared to controls from patients with malaria, Africans living in areas not endemic for these infections and healthy Germans. The investigation comprised the determination of the eosinophil granule proteins eosinophil cationic protein (ECP) and eosinophil-derived neurotoxin (EDN/EPX), and the neutrophil/monocyte granule protein myeloperoxidase (MPO). ECP and EDN/EPX levels were found elevated only in the three helminth infections that are associated with eosinophilia, while MPO was found elevated in all tested disease groups. The levels of eosinophil granule proteins observed in the helminth diseases by far exceeded those described for bronchial asthma and atopic dermatitis. ECP, EDN/EPX and MPO serum levels reflect the ongoing disease and are related to functional activity of the respective leukopoetic system. ECP and EDN/EPX appear to be markers of the eosinophil effector system and MPO a marker of the neutrophil and/or monocyte/macrophage effector system. Significantly higher ECP levels in chronic hyperreactive onchodermatitis (sowda) versus generalized onchocerciasis seem to reflect an augmented degree of antigenic stimulation, eosinophil activation and eosinophil turnover rates, indicating a more active mechanism of parasite clearance in sowda patients.
引用
收藏
页码:171 / 182
页数:12
相关论文
共 50 条
  • [31] Once-daily theophylline reduces serum eosinophil cationic protein and eosinophil levels in induced sputum of asthmatics
    Aizawa, H
    Iwanaga, T
    Inoue, T
    Takata, S
    Matsumoto, K
    Takahashi, N
    Yoshida, M
    Hara, N
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2000, 121 (02) : 123 - 128
  • [32] Molecular recognition of human eosinophil-derived neurotoxin (RNase 2) by placental ribonuclease inhibitor
    Iyer, S
    Holloway, DE
    Kumar, K
    Shapiro, R
    Acharya, KR
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2005, 347 (03) : 637 - 655
  • [33] Montelukast treatment response according to eosinophil-derived neurotoxin level in children with allergic rhinitis
    Lee, Yong Ju
    Ma, Hyo-Sun
    Callaway, Zak
    Kim, Chang-Keun
    [J]. JOURNAL OF ASTHMA, 2024, 61 (12) : 1611 - 1618
  • [34] Fecal Calprotectin and Eosinophil-derived Neurotoxin in Healthy Children Between 0 and 12 Years
    Roca, Maria
    Rodriguez Varela, Ana
    Donat, Ester
    Cano, Francisco
    Hervas, David
    Armisen, Ana
    Vaya, Maria J.
    Sjolander, Anders
    Ribes-Koninckx, Carmen
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2017, 65 (04) : 394 - 398
  • [35] Eosinophil-derived neurotoxin, elastase, and cytokine profile in effusion from eosinophilic otitis media
    Uchimizu, Hirotaka
    Matsuwaki, Yoshinori
    Kato, Masahiko
    Otori, Nobuyosi
    Kojima, Hiromi
    [J]. ALLERGOLOGY INTERNATIONAL, 2015, 64 : S18 - S23
  • [36] Serum eosinophil cationic protein, myeloperoxidase, tryptase, eotaxin and Th2-like cytokines in dermatitis herpetiformis
    Caproni, M
    Cardinali, C
    D'Agata, A
    Selvaggi, W
    Fabbri, P
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2002, 128 (01) : 67 - 72
  • [37] Effect of immunotherapy on serum levels of eosinophil cationic protein in perennial allergic rhinitis
    Ohashi, Y
    Nakai, Y
    Kakinoki, Y
    Ohno, Y
    Sakamoto, H
    Kato, A
    Tanaka, A
    [J]. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1997, 106 (10) : 848 - 853
  • [38] The effect of immunotherapy on the serum levels of eosinophil cationic protein in seasonal allergic rhinitis
    Ohashi, Y
    Nakai, Y
    Kakinoki, Y
    Ohno, Y
    Okamoto, H
    Sakamoto, H
    Kato, A
    Tanaka, A
    [J]. CLINICAL OTOLARYNGOLOGY, 1997, 22 (02): : 100 - 105
  • [39] Serum levels of eosinophil cationic protein in allergic diseases and natural allergen exposure
    Tomassini, M
    Magrini, L
    DePetrillo, G
    Adriani, E
    Bonini, S
    Balsano, F
    Bonini, S
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (06) : 1350 - 1355
  • [40] Measurement of serum levels of eosinophil cationic protein in the diagnosis of acute gastrointestinal anisakiasis
    Domínguez-Ortega, J
    Martínez-Alonso, JC
    Alonso-Llamazares, A
    Argüelles-Grande, C
    Chamorro, M
    Robledo, T
    Palacio, R
    Martínez-Cócera, C
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (05) : 453 - 457